Aurora Cannabis Inc
ACB Nasdaq Medicinal Chemicals & Botanical Products Financials FY2018โFY2026
Revenue
Total sales reported in the income statement.
$232M
11.7%
vs prior year
Operating margin
Operating income as a share of revenue.
โ
Net income
Profit after all expenses, interest and tax.
โ$98.4M
8,700.8%
Free cash flow
Cash from operations minus capital spending.
โ
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โ
Market cap
Last close times the latest diluted share count, so it is approximate.
โ
P/E
Last close divided by diluted earnings per share over the last four quarters.
โ
On โ$1.55 EPS (TTM)
What Aurora Cannabis Inc does
No business description yet.
- Legal name
- AURORA CANNABIS INC
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 40-F ยท Jun 11, 2026
- Accession ยท CIK
- 0001628280-26-042364
0001683541
Revenue and margins
Aurora Cannabis Inc had $232M of revenue in fiscal 2026, up 11.7% on the year before.
FY18
Revenue $43.5M
FY19
Revenue $185M
FY20
Revenue $200M
FY21
Revenue $191M
FY22
Revenue $175M
FY24
Revenue โ
FY25
Revenue $208M
FY26
Revenue $232M
FY18
Gross 78.8%
Operating โ173.5%
Net 130.3%
FCF โ396.1%
FY19
Gross 58.0%
Operating โ129.6%
Net โ119.5%
FCF โ247.0%
FY20
Gross โ7.4%
Operating โ173.3%
Net โ1,221.7%
FCF โ
FY21
Gross โ8.8%
Operating โ115.3%
Net โ282.2%
FCF โ107.5%
FY22
Gross 9.6%
Operating โ104.6%
Net โ776.0%
FCF โ64.4%
FY24
Gross โ
Operating โ
Net โ
FCF โ
FY25
Gross 62.6%
Operating 1.7%
Net 0.6%
FCF โ
FY26
Gross 42.6%
Operating โ
Net โ42.4%
FCF โ
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY18
Net income $56.6M
FY19
Net income โ$222M
FY20
Net income โ$2.4B
FY21
Net income โ$539M
FY22
Net income โ$1.4B
FY24
Net income โ
FY25
Net income $1.1M
FY26
Net income โ$98.4M
Q4 '22
Net income $0.0M
Q1 '25
Net income $2.7M
Q2 '25
Net income โ$9.7M
Q3 '25
Net income $20.2M
Q4 '25
Net income โ$12.0M
FY18
Diluted EPS $0.12
FY19
Diluted EPS โ$0.22
FY20
Diluted EPS โ$25.27
FY21
Diluted EPS โ$3.20
FY22
Diluted EPS โ$6.31
FY24
Diluted EPS โ
FY25
Diluted EPS $0.03
FY26
Diluted EPS โ$1.55
Q4 '22
Diluted EPS โ
Q1 '25
Diluted EPS $0.07
Q2 '25
Diluted EPS โ
Q3 '25
Diluted EPS โ
Q4 '25
Diluted EPS โ
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY18
Return on capital โ6.0%
Return on equity 4.8%
Return on assets 4.0%
FY19
Return on capital โ5.7%
Return on equity โ9.8%
Return on assets โ7.9%
FY20
Return on capital โ17.1%
Return on equity โ99.4%
Return on assets โ78.4%
FY21
Return on capital โ
Return on equity โ33.6%
Return on assets โ26.1%
FY22
Return on capital โ83.4%
Return on equity โ125.8%
Return on assets โ92.3%
FY24
Return on capital โ
Return on equity โ
Return on assets โ
FY25
Return on capital 0.9%
Return on equity 0.3%
Return on assets 0.2%
FY26
Return on capital โ
Return on equity โ25.8%
Return on assets โ19.2%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was โ in fiscal 2026, โ of revenue. Cash from operations minus capital spending.
FY18
Free cash flow โ$172M
FY19
Free cash flow โ$458M
FY20
Free cash flow โ
FY21
Free cash flow โ$206M
FY22
Free cash flow โ$113M
FY24
Free cash flow โ
FY25
Free cash flow โ
FY26
Free cash flow โ
FY18
Cash from operations โ$64.3M
Capital spending $108M
FY19
Cash from operations โ$145M
Capital spending $313M
FY20
Cash from operations โ$255M
Capital spending โ
FY21
Cash from operations โ$164M
Capital spending $41.4M
FY22
Cash from operations โ$87.1M
Capital spending $25.5M
FY24
Cash from operations โ
Capital spending โ
FY25
Cash from operations $11.5M
Capital spending โ
FY26
Cash from operations โ$9.8M
Capital spending โ
Cash from operations
Capital spending
Dividends, buybacks and share count
Aurora Cannabis Inc returned โ to shareholders in fiscal 2026. The diluted share count rose 3.0%.
FY18
Dividends โ
Buybacks โ
FY19
Dividends โ
Buybacks โ
FY20
Dividends โ
Buybacks โ
FY21
Dividends โ
Buybacks โ
FY22
Dividends โ
Buybacks โ
FY24
Dividends โ
Buybacks โ
FY25
Dividends โ
Buybacks โ
FY26
Dividends โ
Buybacks โ
Dividends
Buybacks
FY18
Diluted shares 0.47B
FY19
Diluted shares 1.02B
FY20
Diluted shares 0.10B
FY21
Diluted shares 0.17B
FY22
Diluted shares 0.21B
FY24
Diluted shares โ
FY25
Diluted shares 0.06B
FY26
Diluted shares 0.06B
Balance sheet
Cash, debt and the ratios that show how comfortably Aurora Cannabis Inc can carry it.
FY18
Cash $58.0M
Debt $8.8M
FY19
Cash $132M
Debt $108M
FY20
Cash $119M
Debt $149M
FY21
Cash $340M
Debt โ
FY22
Cash $339M
Debt $0.0M
FY24
Cash $100M
Debt $42.2M
FY25
Cash $96.0M
Debt $43.0M
FY26
Cash $46.4M
Debt $0.0M
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $340M | $339M | $100M | $96.0M | $46.4M |
| Debt incl. finance leases | โ | $0.0M | $42.2M | $43.0M | $0.0M |
| Net debt / EBITDA | โ | โ | โ | โ9.3x | โ |
| Debt / equity | โ | 0.0x | 0.1x | 0.1x | 0.0x |
| Interest coverage | โ4.3x | โ3.2x | โ | 2.0x | โ |
| Current ratio | 5.7x | 5.7x | 3.4x | 4.3x | 5.9x |
| Quick ratio | 4.7x | 4.8x | 2.3x | 2.6x | 3.6x |
| Total assets | $2.1B | $839M | $618M | $594M | $431M |
| Total liabilities | $458M | $327M | $174M | $170M | $64.1M |
| Shareholders' equity | $1.6B | $512M | $412M | $395M | $367M |
| Net debt (โ = net cash) | โ | โ$339M | โ$58.1M | โ$53.1M | โ$46.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 2 / 9 | 4 / 9 | 3 / 8 | 3 / 8 | โ / 5 | 4 / 9 |
| Accruals ratio | 8.5% | โ2.7% | โ70.3% | โ18.2% | โ86.4% | โ1.7% | โ17.3% |
| Altman Z'' | 5.17 | 3.85 | โ1.59 | โ0.96 | โ14.25 | โ19.04 | โ |
8 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $43.5M | $185M | $200M | $191M | $175M | โ | $208M | $232M |
| Provision for credit losses | โ | โ | โ | $0.0M | $8.3M | โ | โ | โ |
| Gross profit | $34.3M | $108M | โ$14.8M | โ$16.8M | $16.8M | โ | $130M | $98.8M |
| Research and development | $1.3M | $11.2M | $19.4M | $8.9M | $8.2M | โ | $2.6M | $2.9M |
| Operating income | โ$75.4M | โ$240M | โ$347M | โ$220M | โ$183M | โ | $3.6M | โ |
| Interest expense | $9.3M | $29.8M | $56.7M | $51.8M | $56.7M | โ | $1.8M | $1.3M |
| Pretax income | $60.9M | โ$250M | โ$2.5B | โ$546M | โ$1.4B | โ | $22.5M | โ$40.9M |
| Income tax | $6.4M | โ$22.6M | โ$61.2M | โ$4.9M | โ$1.7M | โ | $3.1M | $1.5M |
| Net income | $56.6M | โ$222M | โ$2.4B | โ$539M | โ$1.4B | โ | $1.1M | โ$98.4M |
| Net income to common | $56.6M | โ$222M | โ$2.4B | โ$539M | โ$1.4B | โ | โ | โ |
| Diluted EPS | $0.12 | โ$0.22 | โ$25.27 | โ$3.20 | โ$6.31 | โ | $0.03 | โ$1.55 |
| Diluted shares | 0.47B | 1.02B | 0.10B | 0.17B | 0.21B | โ | 0.06B | 0.06B |
| Cash flow | ||||||||
| Cash from operations | โ$64.3M | โ$145M | โ$255M | โ$164M | โ$87.1M | โ | $11.5M | โ$9.8M |
| Capital expenditure | $108M | $313M | โ | $41.4M | $25.5M | โ | โ | โ |
| Free cash flow | โ$172M | โ$458M | โ | โ$206M | โ$113M | โ | โ | โ |
| Depreciation and amortization | $9.5M | $47.8M | $50.3M | $38.3M | $38.4M | โ | $2.1M | $2.8M |
| Stock-based compensation | $29.5M | $80.8M | $44.1M | $15.8M | $10.9M | โ | $8.3M | $5.3M |
| Acquisitions | $84.4M | โ$86.3M | โ$0.2M | $0.0M | $18.3M | โ | $0.0M | โ |
| Balance sheet | ||||||||
| Cash and short-term investments | $58.0M | $132M | $119M | $340M | $339M | $100M | $96.0M | $46.4M |
| Total debt | $8.8M | $108M | $149M | โ | $0.0M | $42.2M | $43.0M | $0.0M |
| Current assets | $166M | $505M | $305M | $538M | $577M | $314M | $333M | $285M |
| Current liabilities | $56.7M | $333M | $199M | $93.9M | $101M | $91.8M | $77.2M | $48.0M |
| Inventory | $22.3M | $85.1M | $99.3M | $94.8M | $89.8M | $106M | $131M | $111M |
| Property and equipment, net | $186M | $585M | $692M | $489M | $181M | $194M | โ | โ |
| Goodwill | $574M | $2.4B | $678M | $717M | $0.0M | $31.8M | $30.5M | $19.1M |
| Intangible assets | $151M | $526M | $301M | $297M | $54.7M | $30.1M | $31.4M | $22.6M |
| Total assets | $1.4B | $4.2B | $2.0B | $2.1B | $839M | $618M | $594M | $431M |
| Total liabilities | $252M | $850M | $480M | $458M | $327M | $174M | $170M | $64.1M |
| Shareholders' equity | $1.2B | $3.3B | $1.6B | $1.6B | $512M | $412M | $395M | $367M |
| Margins | ||||||||
| Gross margin | 78.8% | 58.0% | โ7.4% | โ8.8% | 9.6% | โ | 62.6% | 42.6% |
| Operating margin | โ173.5% | โ129.6% | โ173.3% | โ115.3% | โ104.6% | โ | 1.7% | โ |
| EBITDA margin | โ151.6% | โ103.8% | โ148.2% | โ95.3% | โ82.6% | โ | 2.7% | โ |
| Net margin | 130.3% | โ119.5% | โ1,221.7% | โ282.2% | โ776.0% | โ | 0.6% | โ42.4% |
| FCF margin | โ396.1% | โ247.0% | โ | โ107.5% | โ64.4% | โ | โ | โ |
| Returns | ||||||||
| Return on capital | โ6.0% | โ5.7% | โ17.1% | โ | โ83.4% | โ | 0.9% | โ |
| Return on capital employed | โ5.5% | โ6.2% | โ18.9% | โ11.0% | โ24.8% | โ | 0.7% | โ |
| Return on equity | 4.8% | โ9.8% | โ99.4% | โ33.6% | โ125.8% | โ | 0.3% | โ25.8% |
| Return on assets | 4.0% | โ7.9% | โ78.4% | โ26.1% | โ92.3% | โ | 0.2% | โ19.2% |
| Return on tangible equity | 12.8% | โ55.6% | โ414.4% | โ85.4% | โ296.7% | โ | 0.3% | โ30.2% |
| Growth | ||||||||
| Revenue growth | โ | 326.7% | 7.9% | โ4.5% | โ8.5% | โ | โ | 11.7% |
| Net income growth | โ | โ491.4% | โ | โ | โ | โ | โ | โ8,700.8% |
| EPS growth | โ | โ285.4% | โ | โ | โ | โ | โ | โ5,493.7% |
| Share count change | โ | 115.5% | โ90.5% | 74.8% | 27.1% | โ | โ | 3.0% |
| Financial health | ||||||||
| Net debt / EBITDA | โ | โ | โ | โ | โ | โ | โ9.3x | โ |
| Debt / equity | 0.0x | 0.0x | 0.1x | โ | 0.0x | 0.1x | 0.1x | 0.0x |
| Interest coverage | โ8.1x | โ8.1x | โ6.1x | โ4.3x | โ3.2x | โ | 2.0x | โ |
| Current ratio | 2.9x | 1.5x | 1.5x | 5.7x | 5.7x | 3.4x | 4.3x | 5.9x |
| Quick ratio | 2.5x | 1.3x | 1.0x | 4.7x | 4.8x | 2.3x | 2.6x | 3.6x |
| Capital allocation | ||||||||
| Capex / revenue | 248.1% | 168.7% | โ | 21.6% | 14.6% | โ | โ | โ |
| Stock comp / revenue | 67.8% | 43.6% | 22.0% | 8.3% | 6.2% | โ | 4.0% | 2.3% |
| Quality scores | ||||||||
| Piotroski F-score | โ | 2.0 | 4.0 | 3.0 | 3.0 | โ | โ | 4.0 |
| Altman Z'' | 5.2 | 3.9 | โ1.6 | โ1.0 | โ14.2 | โ | โ19.0 | โ |
| Accruals ratio | 8.5% | โ2.7% | โ70.3% | โ18.2% | โ86.4% | โ | โ1.7% | โ17.3% |
Source: SEC EDGAR XBRL filings (CIK 0001683541). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only โ not investment advice. Check the original filings before relying on any figure.